Rosalind Advisors »

Lipocine shares owned by Rosalind Advisors

Quarter-by-quarter ownership of Lipocine (LPCN) shares owned by Rosalind Advisors from 13F filings

Historical chart of Rosalind Advisors investment in Lipocine

Tip: Access up to 7 years of quarterly data

All positions including Lipocine held by Rosalind Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lipocine by Rosalind Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.8M 222k 7.99

More positions owned by Rosalind Advisors

Delcath Systems Com New (DCTH)
Xeris Pharmaceuticals (XERS)
Fennec Pharmaceuticals (FENC)
Savara (SVRA)
Vaxcyte (PCVX)
Eyepoint Pharmaceuticals Com New (EYPT)
X4 Pharmaceuticals Com New (XFOR)
Vor Biopharma Com New (VOR)
Mediwound Shs New (MDWD)
Verastem Com New (VSTM)
Celldex Therapeutics Com New (CLDX)
BioCryst Pharmaceuticals (BCRX)
Cybin Com New (HELP)
Cg Oncology (CGON)
Inspiremd (NSPR)

View all positions for Rosalind Advisors

Top funds holding Lipocine

Ikarian Capital
Squadron Capital Management
Eversept Partners
Vanguard Group
Rosalind Advisors
Vanguard Capital Management
AIGH Capital Management
Stempoint Capital
Boothbay Fund Management
Seven Fleet Capital Management
Birchview Capital
BlackRock
Mink Brook Asset Management
Geode Capital Management
Exome Asset Management

View all funds holding Lipocine